ProPhase Labs regains Nasdaq compliance after annual meeting; all director nominees elected

ProPhase Labs, Inc.

All four director nominees (Karkus, Gleckel, Hirsch, Abenante) elected; say-on-pay approved with 85.3% support.
Stockholders selected 3-year frequency for say-on-pay; board adopts, next vote in 2028.
Newly elected Abenante appointed to Audit Committee, making it three independent directors, regaining Nasdaq compliance.
Company notified Nasdaq it has regained compliance with Rule 5605(c)(2)(A).

item 5.07item 8.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.